Acute Effects of Fitness Drink Formulas on Energy Expenditure and Fat Metabolism
NCT04455009, Not applicable, Completed, University of Central Florida
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Acute Effects of Fitness Drink Formulas on Energy Expenditure and Fat Metabolism | ClinicalTrials.gov |
| NCT number | NCT04455009 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 56 participants, actual | ClinicalTrials.gov |
| Lead sponsor | University of Central Florida | ClinicalTrials.gov |
| Conditions | Caffeine, Diet, Healthy, Fat Burn, Cognitive Change, Fatigue | ClinicalTrials.gov |
| Interventions | Fitness Drink Formula | ClinicalTrials.gov |
| First posted | 2020-07-02 | ClinicalTrials.gov |
| Last updated | 2020-07-02 | ClinicalTrials.gov |
Registered outcomes 11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in resting energy expenditure/substrate oxidation | Baseline, 30, 60, and 90 min post-ingestion | Estimates from gas exchange analysis via indirect calorimetry | ClinicalTrials.gov |
| Primary | Change in energy expenditure/substrate oxidation in response to exercise | >90 min post-ingestion (pre/peri/post maximal graded exercise test) | Estimates from gas exchange analysis via indirect calorimetry | ClinicalTrials.gov |
| Primary | Change in resting serum glycerol | Baseline, 30, 60, and 90 min post-ingestion | Obtained from blood draw of the superficial forearm vein | ClinicalTrials.gov |
| Primary | Change in oxygen consumption/carbon dioxide production in response to exercise | >90 min post-ingestion (pre/peri/post maximal graded exercise test) | Estimates from gas exchange analysis via indirect calorimetry | ClinicalTrials.gov |
| Primary | Change in resting minute ventilation | Baseline, 30, 60, and 90 min post-ingestion | Estimates from gas exchange analysis via indirect calorimetry | ClinicalTrials.gov |
| Primary | Change in minute ventilation in response to exercise | >90 min post-ingestion (pre/peri/post maximal graded exercise test) | Estimates from gas exchange analysis via indirect calorimetry | ClinicalTrials.gov |
| Secondary | Change in Automated Neuropsychological Assessment Metrics (ANAM) screening | Baseline, 30, 60, and 90 min post-ingestion | Measures from mood scale, go/no go test, Stroop test | ClinicalTrials.gov |
| Secondary | Change in resting blood pressure response | Baseline, 30, 60, and 90 min post-ingestion | Measured via automated blood pressure monitor | ClinicalTrials.gov |
| Secondary | Change in resting heart rate/heart rate variability | Baseline, 30, 60, and 90 min post-ingestion | Measured via chest-based heart rate monitor | ClinicalTrials.gov |
| Secondary | Change in heart rate/heart rate variability in response to exercise | >90 min post-ingestion (pre/peri/post maximal graded exercise test) | Measured via chest-based heart rate monitor | ClinicalTrials.gov |
| Secondary | Change in power output | >90 min post-ingestion | Obtained via cycle ergometer during the maximal graded exercise test | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Go/No-Go Task | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)